menu
    • menu

    Company profile for Lexeo Therapeutics

    NEW Drugs in Dev: 6
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    LEXEO Therapeutics is a New York City based clinical stage gene therapy biotechnology company with a focus on hereditary and acquired diseases of high unmet need. Founded in 2018 based on 25 years of research at a leading scientific institution, LEXEO's investigational therapies have the potential to offer gene therapy based treatments to address many diseases that have eluded today's existing drug delivery platforms. Our mis...
    LEXEO Therapeutics is a New York City based clinical stage gene therapy biotechnology company with a focus on hereditary and acquired diseases of high unmet need. Founded in 2018 based on 25 years of research at a leading scientific institution, LEXEO's investigational therapies have the potential to offer gene therapy based treatments to address many diseases that have eluded today's existing drug delivery platforms. Our mission at LEXEO is to lead the field of gene therapy as a fully integrated biotechnology company; discovering, developing and delivering treatments and cures to some of today's most devastating diseases

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Lexeo TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    430 East 29th Street, 14th Floor, New York, NY 10016
    Telephone
    Telephone
    (212) 547-9879
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.lexeotx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lexeo Therapeutics Hosts Virtual KOL Event at CVCT Forum
    Lexeo Therapeutics Hosts Virtual KOL Event at CVCT Forum

    04 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/04/3199749/0/en/Lexeo-Therapeutics-to-Host-Virtual-Key-Opinion-Leader-Event-at-the-22nd-Global-Cardiovascular-Clinical-Trialists-CVCT-Forum.html

    GLOBENEWSWIRE
    04 Dec 2025
    Share Share
    Lexeo Therapeutics Unveils Q3 2025 Financials & Operations Update
    Lexeo Therapeutics Unveils Q3 2025 Financials & Operations Update

    05 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/05/3181363/0/en/Lexeo-Therapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Operational-Highlights.html

    GLOBENEWSWIRE
    05 Nov 2025
    Share Share
    Lexeo Closes Public Offering, Private Placement & Full Option
    Lexeo Closes Public Offering, Private Placement & Full Option

    20 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/20/3169762/0/en/Lexeo-Therapeutics-Announces-Closing-of-Public-Offering-and-Concurrent-Private-Placement-and-Exercise-in-Full-of-the-Underwriters-Option-to-Purchase-Additional-Shares-in-the-Public.html

    GLOBENEWSWIRE
    20 Oct 2025
    Share Share
    Lexeo Therapeutics Plans Stock Offering And Pre-Funded Warrants
    Lexeo Therapeutics Plans Stock Offering And Pre-Funded Warrants

    16 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/16/3168360/0/en/Lexeo-Therapeutics-Announces-Proposed-Offering-of-Common-Stock-and-Pre-Funded-Warrants.html

    GLOBENEWSWIRE
    16 Oct 2025
    Share Share
    Lexeo Therapeutics Advances FDA Talks For Accelerated Approval
    Lexeo Therapeutics Advances FDA Talks For Accelerated Approval

    07 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/07/3162307/0/en/Lexeo-Therapeutics-Announces-Progress-in-FDA-Discussions-for-Accelerated-Approval-Pathway-and-Positive-Interim-Clinical-Data-for-LX2006-in-Friedreich-Ataxia-Cardiomyopathy.html

    GLOBENEWSWIRE
    07 Oct 2025
    Share Share
    Lexeo Therapeutics Reports Q2 2025 Financial Results
    Lexeo Therapeutics Reports Q2 2025 Financial Results

    14 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/14/3133352/0/en/Lexeo-Therapeutics-Reports-Second-Quarter-2025-Financial-Results-and-Operational-Highlights.html

    GLOBENEWSWIRE
    14 Aug 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search